In a groundbreaking partnership, the Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) have teamed up with Chem ID Ltd to revolutionise the UK’s legal cannabis industry’s commitment to product authenticity, validation, and quality assurance.
The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) are delighted to announce a strategic partnership with Chem ID Ltd, a leading provider of chemical data standardisation, validation, and traceability solutions. This collaboration will enable ACI and CMC’s members to enhance their commitment to product authenticity, validation, and quality assurance within the commercial cannabis extract and medical cannabis markets in the UK and Europe.
Chem ID’s cloud-based data platform offers a comprehensive solution that ensures the integrity and security of chemical data. By utilising Chem ID’s technology, ACI and CMC members will have the means to guarantee the authenticity and quality of their respective products, promoting consumer, retailer, regulator, patient and prescribers trust and confidence in the rapidly growing cannabis industry.
“Partnering with Chem ID allows us to take a significant step forward in ensuring the supply chain transparency and reliability of CBD products,” said Dr Parveen Bhatarah, Regulatory and Compliance Associate, ACI. “By leveraging Chem ID’s cutting-edge technology, we can provide our members with the tools necessary to meet regulatory requirements and drive the growth of the legal cannabis extract market.”
The Centre for Medicinal Cannabis has played a vital role in advocating for positive reform within the UK’s nascent medical cannabis industry. “At CMC, we are constantly striving to advance the standards and regulations surrounding medical cannabis,” stated Professor Trevor Jones, chief scientific advisor, CMC. “Through our partnership with Chem ID, we aim to further solidify our commitment to ensuring product integrity and quality for the benefit of patients who are prescribed CBPMs [cannabis-based products for medicinal use].”
Chem ID’s hardware-agnostic approach empowers various stakeholders in the cannabis industry, including brand owners, analytical labs, processors, contract manufacturers, farmers, distributors, logistical providers, and regulators. The cloud-based platform offers a centralised hub for chemical data, facilitating standardised and secure communication across the supply chain.
“Chem ID is proud to collaborate with ACI and CMC in their mission to provide reliable cannabis products,” said Alex Andrawes, CEO of Chem ID. “Our solution is backed by a decade of extensive involvement within the cannabis testing ecosystem. This experience allows us to offer unparalleled expertise in regulatory and commercial aspects, understanding what truly works and what doesn’t work. Chem ID has built chemical data management solutions that carry the industry forward into maturity by leveraging powerful AI tools to improve product development, process flow, risk reduction, improving cost efficiencies and future proofing. The outcome is a transparent industry with a strong emphasis on public safety via truth-in-labeling, thereby building consumer confidence and trust.”
This partnership will open doors for ACI and CMC members to confidently expand market access and business growth opportunities.
About ACI
The Association for the Cannabinoid Industry (ACI) is a membership organisation dedicated to nurturing a safe, legal, and thriving commercial cannabis extract market in the UK and Europe. ACI members represent a diverse range of businesses committed to upholding the highest standards of quality and safety in the industry.
About CMC
The Centre for Medicinal Cannabis is a leading organisation at the forefront of medical cannabis research, advocacy, and policy reform. CMC utilises its expertise and network to drive positive change, ensuring patient access to safe and effective medicinal cannabis products.
About Chem ID Ltd
Chem ID Ltd provides cutting-edge solutions for chemical data standardisation, validation, traceability, and securitisation. Their cloud-based data platform serves as a central hub for chemical information, empowering stakeholders across the cannabis industry to maximise profit potential while meeting regulatory requirements.
